Ambulatory Hypertension in Pediatric Patients With Sickle Cell Disease and Its Association With End-Organ Damage.

ambulatory blood pressure monitoring end-organ complications estimated glomerular filtration rate hypertension microalbuminuria sickle cell disease

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
25 Nov 2020
Historique:
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 5 1 2021
Statut: epublish

Résumé

Background Sickle cell disease (SCD), a chronic hemolytic disorder, results in cumulative end-organ damage affecting major organs such as the cardiovascular, renal, and central nervous systems. Effects of modifiable risk factors, such as blood pressure (BP), on the development of end-organ complications in SCD have not been well studied, particularly among the pediatric population. Relative hypertension in patients with SCD increases their risks of stroke, cardiovascular complications, and death. The primary hypothesis of this study was that abnormal BP patterns are common among patients with SCD and they impact end-organ complications. Methods Patients with SCD (HbSS, HbSβ0) were enrolled from the Children's Hospital at Montefiore (N = 100). For each patient, demographic data were collected, biochemical variables in urine and blood samples were analyzed, BP was determined with ambulatory blood pressure monitoring (ABPM), and an echocardiogram was performed. The prevalence of abnormalities in BP parameters was defined, and their relationships with measures of SCD severity and end-organ damage were assessed. Results Sufficient ABPM data were available for 67 patients. Enrolled children were 13 ± 4 years (40% were males). Assessment of diurnal variation demonstrated that 81% of patients had abnormal systolic nocturnal dipping and 61% had abnormal diastolic nocturnal dipping. Abnormalities in the diurnal pattern were associated with reticulocytosis and hyperfiltration. Microalbuminuria was present in 19% (n = 13) of patients, of which 77% (n = 10) were females (p = 0.014). Diastolic load and abnormal nocturnal dipping were associated with hyperfiltration but not with microalbuminuria. Conclusions BP abnormalities detected with ABPM in SCD patients are prevalent and perhaps are a risk factor for end-organ complications. Further studies are required to identify the mechanisms underlying these relationships and their longitudinal changes.

Identifiants

pubmed: 33391940
doi: 10.7759/cureus.11707
pmc: PMC7769822
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e11707

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001073
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002556
Pays : United States

Informations de copyright

Copyright © 2020, Ranabothu et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cardiovasc Diabetol. 2010 Aug 13;9:36
pubmed: 20704750
Cardiorenal Med. 2011;1(3):183-192
pubmed: 22096454
Arch Intern Med. 1982 Jun;142(6):1239-40
pubmed: 7092436
BMC Nephrol. 2013 Oct 30;14:237
pubmed: 24168027
Hypertension. 2017 Oct;70(4):683-686
pubmed: 28827475
J Am Soc Hypertens. 2018 Jul;12(7):542-550
pubmed: 29804939
J Am Soc Hypertens. 2018 Dec;12(12):850-857
pubmed: 30219649
Pediatr Nephrol. 2011 Aug;26(8):1285-90
pubmed: 21559933
Hypertension. 2019 Jan;73(1):148-152
pubmed: 30571555
Hypertension. 2014 May;63(5):1116-35
pubmed: 24591341
ScientificWorldJournal. 2008 Dec 25;8:1295-324
pubmed: 19112541
Am J Kidney Dis. 2007 Feb;49(2 Suppl 2):S12-154
pubmed: 17276798
Blood. 2020 Mar 26;135(13):1049-1057
pubmed: 31932840
Nat Rev Nephrol. 2015 Mar;11(3):161-71
pubmed: 25668001
Am J Hematol. 2010 Jan;85(1):36-40
pubmed: 20029950
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Chest. 1990 Nov;98(5):1169-74
pubmed: 2146092
J Clin Invest. 1956 Sep;35(9):998-1007
pubmed: 13367196
Kidney Int Rep. 2016 Jul;1(2):94-104
pubmed: 28164170
Lancet. 2010 Dec 11;376(9757):2018-31
pubmed: 21131035
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356
PLoS One. 2019 Jan 10;14(1):e0210591
pubmed: 30629671
Pediatr Blood Cancer. 2014 Mar;61(3):518-22
pubmed: 24424792
Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21
pubmed: 20331952
J Am Soc Nephrol. 2006 Aug;17(8):2228-35
pubmed: 16837635
Pediatr Blood Cancer. 2011 May;56(5):762-6
pubmed: 21370408
J Am Soc Echocardiogr. 2010 May;23(5):465-95; quiz 576-7
pubmed: 20451803
Hypertension. 2012 Jul;60(1):43-50
pubmed: 22585950
Pediatr Nephrol. 2013 Jan;28(1):115-20
pubmed: 22886281

Auteurs

Saritha Ranabothu (S)

Pediatrics, University of Arkansas for Medical Sciences, Little Rock, USA.

Michael Hafeman (M)

Pediatrics, Albert Einstein College of Medicine, Bronx, USA.

Deepa Manwani (D)

Hematology, Children's Hospital at Montefiore, Bronx, USA.

Kimberly Reidy (K)

Nephrology, Children's Hospital at Montefiore, Bronx, USA.

Kerry Morrone (K)

Hematology, Children's Hospital at Montefiore, Bronx, USA.

Josemiguel Lorenzo (J)

Cardiology, Children's Hospital at Montefiore, Bronx, USA.

Barbara Tria (B)

Cardiology, Children's Hospital at Montefiore, Bronx, USA.

Frederick Kaskel (F)

Nephrology, Children's Hospital at Montefiore, Bronx, USA.

Joseph Mahgerefteh (J)

Cardiology, Children's Hospital at Montefiore, Bronx, USA.

Classifications MeSH